Scientists at Pennington Biomedical Research Center, along with a colleague from Peking University People's Hospital in China ...

Dr. Marion has assembled a team of high-profile, experienced pharmaceutical executives, former senior FDA members, and academic scientists to lead the development of PATAS. He has also established ...

The Dasman Diabetes Institute has reduced diabetes medications for patients by 50 percent through its Diabetes Overcome ...

Fructose, the most common food sweetener, is widely used in processed sugary beverages, candies, and baked goods. Excessive ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

November is Diabetes Awareness Month and the chronic disease remains one of the most common in the United States.

Elevated IL-10 in diabetes causes capillary obstruction, linked to cognitive deficits. Blocking IL-10 receptors shows promise for improving brain function.

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...